Ensign Peak Advisors’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-20,850
Closed -$1.3M 1760
2023
Q4
$1.3M Buy
20,850
+5,450
+35% +$305K ﹤0.01% 1179
2023
Q3
$864K Hold
15,400
﹤0.01% 1311
2023
Q2
$777K Hold
15,400
﹤0.01% 1443
2023
Q1
$840K Hold
15,400
﹤0.01% 1389
2022
Q4
$963K Buy
15,400
+7,000
+83% +$465K ﹤0.01% 1188
2022
Q3
$592K Buy
8,400
+1,950
+30% +$135K ﹤0.01% 1365
2022
Q2
$366K Hold
6,450
﹤0.01% 1589
2022
Q1
$404K Buy
6,450
+760
+13% +$41K ﹤0.01% 1646
2021
Q4
$319K Buy
+5,690
New +$348K ﹤0.01% 1796

Other funds holding AXNX

Ensign Peak Advisors's AXNX Position: Q1 2024 in Review

Ensign Peak Advisors sold out of Axonics, Inc. Common Stock (AXNX) in Q1 2024, closing a stake of 20,850 shares — an estimated $1.3M sold.

Ensign Peak Advisors first reported a position in AXNX in Q4 2021 and held it in 9 quarters. The position peaked at $1.3M in Q4 2023. 235 funds tracked by Wall St. Rank hold AXNX as of Q1 2024.

  • Ensign Peak Advisors reported no remaining Axonics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Ensign Peak Advisors sold 20,850 Axonics, Inc. Common Stock shares in Q1 2024, an estimated $1.3M.
  • Ensign Peak Advisors first reported a position in Axonics, Inc. Common Stock in Q4 2021 and held it in 9 quarters.
  • Ensign Peak Advisors's Axonics, Inc. Common Stock position peaked at $1.3M in Q4 2023.
  • 235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q1 2024.

Based on Ensign Peak Advisors's 13F filing for Q1 2024, filed 14 May 2024.